Prospera Financial Services Inc Neurocrine Biosciences Inc Transaction History

Prospera Financial Services Inc

  • $4.16 Billion
  • Q4 2024

A detailed history of Prospera Financial Services Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Prospera Financial Services Inc holds 2,591 shares of NBIX stock, worth $292,886. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,591
Previous 2,582 0.35%
Holding current value
$292,886
Previous $297,000 18.86%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$111.62 - $139.44 $1,004 - $1,254
9 Added 0.35%
2,591 $353,000
Q3 2024

Nov 07, 2024
SELL
$114.58 - $153.15 $2,749 - $3,675
-24 Reduced 0.92%
2,582 $297,000
Q2 2024

Aug 13, 2024
SELL
$130.86 - $143.19 $30,490 - $33,363
-233 Reduced 8.21%
2,606 $358,000
Q1 2024

Aug 13, 2024
BUY
$130.4 - $143.74 $43,423 - $47,865
333 Added 12.78%
2,939 $405,000
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $9,015 - $11,284
-85 Reduced 2.91%
2,839 $374,000
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $6,863 - $8,548
-73 Reduced 2.44%
2,924 $328,000
Q2 2023

Aug 08, 2023
BUY
$89.53 - $104.87 $268,321 - $314,295
2,997 New
2,997 $282,000
Q2 2022

Aug 08, 2022
SELL
$75.79 - $100.07 $37,591 - $49,634
-496 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$72.45 - $94.81 $35,935 - $47,025
496 New
496 $46,000
Q3 2021

Nov 12, 2021
SELL
$86.18 - $99.03 $1.09 Million - $1.26 Million
-12,679 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$89.43 - $102.27 $1.13 Million - $1.3 Million
12,679 New
12,679 $1.23 Million
Q4 2020

Feb 12, 2021
SELL
$86.91 - $108.33 $869 - $1,083
-10 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$96.16 - $135.15 $961 - $1,351
10 New
10 $1,000

Others Institutions Holding NBIX

# of Institutions
655
Shares Held
96.6M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email